FACET PHARMA ApS: Financial statements 2022
CVR: 66387119
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
FACET PHARMA ApS (CVR 66387119) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -58,103 and a net result of DKK -71,912 compared with DKK -29,931 the year before. Equity in the 2022 report amounted to DKK 264,758. The solvency ratio was 72.7%.
- Gross Profit
- DKK -58,103
- Profit/Loss
- DKK -71,912
- Equity
- DKK 264,758
- Total Assets
- DKK 364,423
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -58 t. | -72 t. | 265 t. | 0 |
| 2021 | - | -18 t. | -30 t. | 337 t. | 1 |
| 2020 | - | 50 t. | 30 t. | 367 t. | 0 |
| 2019 | - | 73 t. | -216 t. | 336 t. | 1 |
| 2018 | - | 505 t. | 31 t. | 553 t. | 1 |
Official annual report
Keep an eye on FACET PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
FACET PHARMA ApS has published its annual report for 2021. Gross profit came to DKK -17,663, and the net result was DKK -29,931.
About FACET PHARMA ApS
FACET PHARMA ApS was a Danish company of the type Anpartsselskab based in Brøndby, founded in 1980. The company has been dissolved on 21 February 2025. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -28,877 and a net result of DKK -10,193 compared with DKK -71,912 the year before. Equity in the 2023 report amounted to DKK 254,565.